Works matching DE "PHYSIOLOGICAL effects of hypoglycemic agents"
Results: 194
Cardiovascular Safety of New Drugs for Diabetes: Getting the Balance Right?
- Published in:
- Pharmaceutical Medicine, 2014, v. 28, n. 3, p. 109, doi. 10.1007/s40290-014-0053-7
- By:
- Publication type:
- Article
Islet protective and insulin secretion property of Murraya koenigii and Ocimum tenuflorum in streptozotocin-induced diabetic mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2012, v. 90, n. 3, p. 371, doi. 10.1139/Y11-133
- By:
- Publication type:
- Article
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/157201
- By:
- Publication type:
- Article
Hypoglycaemia.
- Published in:
- 1999
- Publication type:
- Abstract
A safety update on sodium glucose co‐transporter 2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, p. 34, doi. 10.1111/dom.13611
- By:
- Publication type:
- Article
Comparative risk of genital infections associated with sodium‐glucose co‐transporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 434, doi. 10.1111/dom.13531
- By:
- Publication type:
- Article
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 312, doi. 10.1111/dom.13525
- By:
- Publication type:
- Article
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258
- By:
- Publication type:
- Article
Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 812, doi. 10.1111/dom.12684
- By:
- Publication type:
- Article
Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 820, doi. 10.1111/dom.12687
- By:
- Publication type:
- Article
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 783, doi. 10.1111/dom.12670
- By:
- Publication type:
- Article
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 834, doi. 10.1111/dom.12671
- By:
- Publication type:
- Article
Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 755, doi. 10.1111/dom.12665
- By:
- Publication type:
- Article
Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 766, doi. 10.1111/dom.12666
- By:
- Publication type:
- Article
Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study ( VISION).
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 775, doi. 10.1111/dom.12667
- By:
- Publication type:
- Article
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 795, doi. 10.1111/dom.12672
- By:
- Publication type:
- Article
Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 8, p. 840, doi. 10.1111/dom.12673
- By:
- Publication type:
- Article
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 5, p. 528, doi. 10.1111/dom.12631
- By:
- Publication type:
- Article
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 249, doi. 10.1111/dom.12602
- By:
- Publication type:
- Article
Patient-reported outcomes among patients with type 2 diabetes mellitus treated with dapagliflozin in a triple-therapy regimen for 52 weeks.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 306, doi. 10.1111/dom.12604
- By:
- Publication type:
- Article
Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 258, doi. 10.1111/dom.12605
- By:
- Publication type:
- Article
Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 266, doi. 10.1111/dom.12608
- By:
- Publication type:
- Article
Treatment intensification with an insulin degludec ( IDeg)/insulin aspart ( IAsp) co-formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 274, doi. 10.1111/dom.12609
- By:
- Publication type:
- Article
Comparison of the pharmacokinetics and pharmacodynamics of dapagliflozin in patients with type 1 versus type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 236, doi. 10.1111/dom.12594
- By:
- Publication type:
- Article
Cardiovascular and non-cardiovascular safety of dipeptidyl peptidase-4 inhibition: a meta-analysis of randomized controlled cardiovascular outcome trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 3, p. 295, doi. 10.1111/dom.12595
- By:
- Publication type:
- Article
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 2, p. 186, doi. 10.1111/dom.12582
- By:
- Publication type:
- Article
Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open-flow microperfusion.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1166, doi. 10.1111/dom.12551
- By:
- Publication type:
- Article
Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1158, doi. 10.1111/dom.12554
- By:
- Publication type:
- Article
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 12, p. 1180, doi. 10.1111/dom.12572
- By:
- Publication type:
- Article
A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 10, p. 984, doi. 10.1111/dom.12538
- By:
- Publication type:
- Article
Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 12, p. 1263, doi. 10.1111/1440-1681.12823
- By:
- Publication type:
- Article
KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2014, v. 41, n. 10, p. 748, doi. 10.1111/1440-1681.12280
- By:
- Publication type:
- Article
Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 6, p. 1464, doi. 10.1111/bcp.12740
- By:
- Publication type:
- Article
Therapeutic potential of cyanobacteria against streptozotocin-induced diabetic rats.
- Published in:
- 3 Biotech, 2016, v. 6, n. 1, p. 1, doi. 10.1007/s13205-016-0411-0
- By:
- Publication type:
- Article
A Case of Janumet Poisoning.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Does Citrulline Sit at the Nexus of Metformin's Pleotropic Effects on Metabolism and Mediate Its Salutatory Effects in Individuals With Type 2 Diabetes?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hyperpolarized 13C Magnetic Resonance Treatment Response Monitoring: A New Paradigm for Multiorgan Metabolic Assessment of Pharmacological Interventions?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of Antecedent GABA A Receptor Activation on Counterregulatory Responses to Exercise in Healthy Man.
- Published in:
- Diabetes, 2015, v. 64, n. 9, p. 3253, doi. 10.2337/db15-0212
- By:
- Publication type:
- Article
CLINICAL THERAPEUTICS/NEW TECHNOLOGY--PHARMACOLOGIC TREATMENT OF COMPLICATIONS.
- Published in:
- 2015
- Publication type:
- Abstract
Metformin Inhibits Monocyte-to-Macrophage Dif ferentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis.
- Published in:
- Diabetes, 2015, v. 64, n. 6, p. 2028, doi. 10.2337/db14-1225
- By:
- Publication type:
- Article
Imeglimin Normalizes Glucose Tolerance and Insulin Sensitivity and Improves Mitochondrial Function in Liver of a High-Fat, High-Sucrose Diet Mice Model.
- Published in:
- Diabetes, 2015, v. 64, n. 6, p. 2254, doi. 10.2337/db14-1220
- By:
- Publication type:
- Article
EPIDEMIOLOGY--DIABETES COMPLICATIONS.
- Published in:
- 2014
- Publication type:
- Abstract
The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain.
- Published in:
- Diabetes, 2013, v. 62, n. 4, p. 1289, doi. 10.2337/db12-0988
- By:
- Publication type:
- Article
DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
A Case for the Development of DPP-4 Inhibitors for Stroke Prevention in Diabetes?
- Published in:
- Diabetes, 2013, v. 62, n. 4, p. 1003, doi. 10.2337/db13-ti04
- By:
- Publication type:
- Article
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0701-0
- By:
- Publication type:
- Article
New-onset diabetes after liver transplantation: a national report from China Liver Transplant Registry.
- Published in:
- Liver International, 2016, v. 36, n. 5, p. 705, doi. 10.1111/liv.13042
- By:
- Publication type:
- Article
Diazole and triazole derivatives of castor oil extract: synthesis, hypoglycemic effect, antioxidant potential and antimicrobial activity.
- Published in:
- Grasas y Aceites, 2020, v. 71, n. 4, p. 1, doi. 10.3989/gya.0342191
- By:
- Publication type:
- Article
Absorption, metabolism, and excretion of [<sup>14</sup>C]evogliptin tartrate in male rats and dogs.
- Published in:
- Journal of Toxicology & Environmental Health: Part A, 2018, v. 81, n. 11, p. 453, doi. 10.1080/15287394.2018.1451194
- By:
- Publication type:
- Article
Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients.
- Published in:
- Italian Journal of Medicine, 2016, v. 10, n. 1, p. 36, doi. 10.4081/itjm.2016.558
- By:
- Publication type:
- Article